Review our resources for client conversations.
Help clients understand how our distinct business model funds innovative medical research.
We're always looking for exceptional team members.
By Mike Liss - January 5, 2018
2017 brought with it a lot of uncertainty and speculation around what Congress would do, what lawmakers would or wouldn’t pass and what it all means to our economic landscape. But in my world, no matter what does or doesn’t happen, our approach to value investing remains the same: Identify undervalued companies that make products or have services that are needed. We look for high-quality companies that have good returns on capital. Right now, I have my eye on the energy sector and pharmaceuticals. Watch the video below for rationale on why I believe those sectors present good risk-reward opportunities.
Economic activity around the world is softening, which Sr. Portfolio Manager Brent Puff believes could make finding future growth more challenging.
Investing in small-cap energy companies can be risky. Our portfolio managers discuss two potential solutions to this dilemma.
A fund's batting average is a measure of consistency—the periods of a manager's outperformance divided by the total number of periods.
July 11, 2017
Despite the slowdown in global gross domestic product, global value equity portfolio manager Mike Liss believes a recession is unlikely.
Tariffs. Rising rates. Geopolitical turmoil. None of this deters Sr. Portfolio Manager Mike Liss on his mission to turn high-quality companies underperforming into shareholder return. See which industries are on his radar this quarter.
April 17, 2018
Value equity Sr. PM Mike Liss sees good risk-reward opportunities in the energy and pharmaceutical sectors in 2018.
January 05, 2018
The opinions expressed are those of American Century Investments (or the portfolio manager) and are no guarantee of the future performance of any American Century Investments' portfolio. This material has been prepared for educational purposes only. It is not intended to provide, and should not be relied upon for, investment, accounting, legal or tax advice.